Ultrasound Exposure Improves the Targeted Therapy Effects of Galactosylated Docetaxel Nanoparticles on Hepatocellular Carcinoma Xenografts

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Wei, Hongfen ^a,b   Huang, Jing ^c   Yang, Jing ^a   Zhang, Xiujuan ^a   Lin, Liwu ^a   Xue, Ensheng ^a   Chen, Zhikui ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHUHAI PEOPLE S HOSPITAL ZHUHAI HOSPITAL AFFILIATED WITH JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COPOLYMER; DOCETAXEL; GALACTOSYLATED DOCETAXEL NANOPARTICLE; KI 67 ANTIGEN; NANOPARTICLE; SONOVUE; SURVIVIN; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTRAST ENHANCED ULTRASONOGRAPHY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG SYNTHESIS; DRUG TARGETING; ECHOGRAPHY; ENCAPSULATION; FEMALE; HEMOPERFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LETHAL DOSE; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BLOOD FLOW; TUMOR XENOGRAFT; ULTRASOUND EXPOSURE THERAPY; ULTRASOUND THERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DRUG CARRIERS; FEMALE; GALACTOSE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; KI-67 ANTIGEN; LACTIC ACID; LIVER NEOPLASMS; MALE; MICE; NANOPARTICLES; POLYGLYCOLIC ACID; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; SOUND; TAXOIDS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84874558974     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058133     Document Type: Article

References (32)

1. Parkin D M, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, et al. (2000) Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 32: 1224-1229.
3. Takayasu K, Arii S, Ikai I, Omata M, Okita K, et al. (2006) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131: 461-469.
4. Gan HK, Burgess AW, Clayton AH, Scott AM (2012) Targeting of a conformationally exposed, tumor-specific epitope of EGFR as a strategy for cancer therapy. Cancer Res Jun 1 [Epub ahead of print].
5. Niu G, Murad YM, Gao H, Hu S, Guo N, et al. (2012) Molecular targeting of CEACAM6 using antibody probes of different sizes. J Control Release 161: 18-24.
6. Thaci B, Ahmed AU, Ulasov IV, Tobias AL, Han Y, et al. (2012) Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeteddelivery of the therapeutic payload in an orthotopic brain tumor model. Cancer Gene Ther 19: 431-42.
7. Xu Z, Chen L, Gu W, Gao Y, Lin L, et al. (2009) The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials 30: 226-232.
8. Lentacker I, Geers B, Demeester J, De Smedt SC, Sanders NN, (2010) Tumor cell killing efficiency of doxorubicin loaded microbubbles after ultrasound exposure. J Control Release 148: e113-114.
9. Suzuki R, Namai E, Oda Y, Nishiie N, Otake S, et al. (2010) Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J Control Release 142: 245-250.
10. Negishi Y, Omata D, Iijima H, Takabayashi Y, Suzuki K, et al. (2010) Enhanced laminin-derived peptide AG73-mediated liposomal gene transfer by bubble liposomes and ultrasound. Mol Pharm 7: 217-226.
11. Managit C, Kawakami S, Yamashita F, Hashida M, (2005) Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes. J Pharm Sci 94: 2266-2275.
12. Kawakami S, Yamashita F, Nishikawa M, Takakura Y, Hashida M, (1998) Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. Biochem Biophys Res Commun 252: 78-83.
13. Chen ZK, Cai MX, Yang J, Lin LW, Xue ES, et al. (2012) Chemotherapy with PLGA microspheres containing docetaxel decreases angiogenesis in human hepatoma xenograft. Med Oncol 29: 62-69.
14. Yata Y, Xue F, Takahara T, Kudo H, Hirano K, et al. (2010) Docetaxel inhibits progression of human hepatoma cell line in vitro and is effective in advanced hepatocellular carcinoma. Hepatol Res 40: 304-310.
15. Li L, Tang F, Liu H, Liu T, Hao N, et al. (2010) In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. Nano 4: 6874-6882.
16. Rottenberg S, Vollebergh MA, de Hoon B, de Ronde J, Schouten PC, et al. (2012) Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors. Cancer Res 72: 2350-2361.
17. Bergh J, Bondarenko IM, Lichinitser MR, Liljegren A, Greil R, et al. (2012) First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study. J Clin Oncol 30: 921-929.
18. van Zuylen L, Verweij J, Sparreboom A, (2001) Role of formulation vehicles in taxane pharmacology. Invest New Drugs 19: 125-141.
19. Fang C, Shi B, Hong MH, Pei YY, Chen HZ, (2006) Influence of particle size and MePEG molecular weight on in vitro macrophage uptake and in vivo long circulating of stealth nanoparticles in rats. Yao Xue Xue Bao 41: 305-312.
20. Oeffinger BE, Wheatley MA, (2004) Development and characterization of a nano-scale contrast agent. Ultrasonics 42: 343-347.
21. Braun JR, Willnow TE, Ishibashi S, Ashwell G, Herz J, (1996) The major subunit of the asialoglycoprotein receptor is expressed on the hepatocellular surface in mice lacking the minor receptor subunit. J Biol Chem 271: 21160-21166.
22. Zhang Y, Rong Qi X, Gao Y, Wei L, Maitani Y, et al. (2007) Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect. J Control Release 117: 281-290.
23. Peng DJ, Sun J, Wang YZ, Tian J, Zhang YH, et al. (2007) Inhibition of hepatocarcinoma by systemic delivery of Apoptin gene via the hepatic asialoglycoprotein receptor. Cancer Gene Ther 14: 66-73.
24. Dong L, Gao S, Diao H, Chen J, Zhang J, (2008) Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo. J Biomed Mater Res A 84: 777-784.
25. Guhagarkar SA, Gaikwad RV, Samad A, Malshe VC, Devarajan PV, (2010) Polyethylene sebacate-doxorubicin nanoparticles for hepatic targeting. Int J Pharm 401: 113-122.
26. Jeong YI, Seo SJ, Park IK, Lee HC, Kang IC, et al. (2005) Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly (gamma-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int J Pharm 296: 151-161.
27. Zheng WY, Kang YY, Li LF, Xu YX, Ma XY, (2011) Levels of effectiveness of gene therapies targeting survivin and its splice variants in human breast cancer cells. Drug Discov Ther 5: 293-298.
28. Lin F, Lin P, Zhao D, Chen Y, Xiao L, et al. (2012) Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis. Cell Prolif 45: 207-216.
29. Ning Y, Li Q, Xiang H, Liu F, Cao J, (2012) Apoptosis induced by 7-difluoromethoxyl- 5,4′-di-n-octyl genistein via the inactivation of FoxM1 in ovarian cancer cells. Oncol Rep 27: 1857-1864.
30. Preusser M, Hoeftberger R, Woehrer A, Gelpi E, Kouwenhoven M, et al. (2012) Prognostic value of Ki67 index in anaplastic oligodendroglial tumours-a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Histopathology 60: 885-894.
31. Pouleau HB, Sadeghi N, Balériaux D, Mélot C, De Witte O, et al. (2012) High levels of cellular proliferation predict pseudoprogression in glioblastoma patients. Int J Oncol 40: 923-928.
32. Lee SH, Hao E, Levine F, Itkin-Ansari P, (2011) Id3 upregulates BrdU incorporation associated with a DNA damage response, not replication, in human pancreatic β-cells. Islets 3: 358-366.